3'-Deoxyparomomycin I supplier

Name
4'''-Deglycosyllividomycin A
EINECS
CAS No. 37636-51-4
Density 1.59g/cm³
Solubility
Melting Point 181°C (rough estimate)
Formula C₂₃H₄₅N₅O₁₃
Boiling Point 910.8 °C at 760 mmHg
Molecular Weight 599.73
Flash Point 504.6 °C
Transport Information
Appearance
Safety
Risk Codes
Molecular Structure
Hazard Symbols
Synonyms Quintomycin D.;3-Deoxyparomomycin I;Lividomycin B.;5-amino-2-(aminomethyl)-6-[5-[3,5-diamino-2-[3-amino-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-hydroxy-cyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxy-oxane-3,4-diol;Quintomycin D;D-Streptamine, O-2-amino-2,3-dideoxy-alpha-D-ribo-hexopyranosyl-(1-4)- O-(O-2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl-(1-3)-beta-D-ribofuranosyl-(1-5))-2-deoxy-;Lividomycin B;D-Streptamine,O-2-amino-2,3-dideoxy-R-Dribo- hexopyranosyl-(1f4)-O-[O-2,6- diamino-2,6-dideoxy-a-L-idopyranosyl- (1f3)-a-D-ribofuranosyl-(1f5)]-2-deoxy-;
PSA 327.09000
LogP -4.33100

3'-Deoxyparomomycin I Specification

The 3'-Deoxyparomomycin I, with CAS registry number 37636-51-4, has the systematic name of 4,6-diamino-2-{[3-O-(2,6-diamino-2,6-dideoxyhexopyranosyl)pentofuranosyl]oxy}-3-hydroxycyclohexyl 2-amino-2,3-dideoxyhexopyranoside. And its classification codes are Drug / Therapeutic Agent and Natural Product.

Physical properties of 3'-Deoxyparomomycin I: (1)ACD/LogP: -3.64; (2)# of Rule of 5 Violations: 3; (3)#H bond acceptors: 18; (4)#H bond donors: 17; (5)#Freely Rotating Bonds: 21; (6)Polar Surface Area: 136.19 Å²; (7)Index of Refraction: 1.662; (8)Molar Refractivity: 139.29 cm³; (9)Molar Volume: 376.3 cm³; (10)Polarizability: 55.22×10^-24cm³; (11)Surface Tension: 98.8 dyne/cm; (12)Enthalpy of Vaporization: 150.33 kJ/mol; (13)Vapour Pressure: 0 mmHg at 25°C.

You can still convert the following datas into molecular structure:
(1)SMILES: O(C2C(OC1OC(CO)C(O)CC1N)C(N)CC(N)C2O)C4OC(C(OC3OC(CN)C(O)C(O)C3N)C4O)CO
(2)InChI: InChI=1/C23H45N5O13/c24-3-10-15(33)16(34)13(28)22(36-10)40-19-12(5-30)38-23(17(19)35)41-20-14(32)6(25)1-7(26)18(20)39-21-8(27)2-9(31)11(4-29)37-21/h6-23,29-35H,1-5,24-28H2
(3)InChIKey: BRSBFYLXCMGALM-UHFFFAOYAW
(4)Std. InChI: InChI=1S/C23H45N5O13/c24-3-10-15(33)16(34)13(28)22(36-10)40-19-12(5-30)38-23(17(19)35)41-20-14(32)6(25)1-7(26)18(20)39-21-8(27)2-9(31)11(4-29)37-21/h6-23,29-35H,1-5,24-28H2
(5)Std. InChIKey: BRSBFYLXCMGALM-UHFFFAOYSA-N

The toxicity data is as follows:

Organism	Test Type	Route	Reported Dose (Normalized Dose)	Source
mouse	LD50	intramuscular	1343ug/kg (1.343mg/kg)	Yakkyoku. Pharmacy. Vol. 31, Pg. 1085, 1980.
mouse	LD50	intravenous	123mg/kg (123mg/kg)	"Antibiotics: Origin, Nature, and Properties," Korzyoski, T., et al., eds., Washington, DC, American Soc. for Microbiology, 1978Vol. 1, Pg. 682, 1978.
mouse	LD50	oral	10gm/kg (10000mg/kg)	Yakkyoku. Pharmacy. Vol. 31, Pg. 1085, 1980.
mouse	LD50	subcutaneous	1245ug/kg (1.245mg/kg)	Yakkyoku. Pharmacy. Vol. 31, Pg. 1085, 1980.

Product Name

4'''-Deglycosyllividomycin A

3'-Deoxyparomomycin I Specification

Related Products

Hot Products